Horst Olschewski
Researcher Next ID · RN-019836
Researcher · Medicine
Sigmund Freud Privatuniversität Wien
Vienna, Austria
- Works count
- 638
- Citation count
- 42,796
- H-index
- 95
- i10-index
- 277
Research interests
Publications
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac237
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
Nature Communications · 2018 · https://doi.org/10.1038/s41467-018-03672-4
Pulmonary hypertension in chronic lung disease and hypoxia
European Respiratory Journal · 2018 · https://doi.org/10.1183/13993003.01914-2018
Updated Clinical Classification of Pulmonary Hypertension
Journal of the American College of Cardiology · 2013 · https://doi.org/10.1016/j.jacc.2013.10.029
Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure
Arthritis & Rheumatism · 2011 · https://doi.org/10.1002/art.33460
Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
Journal of the American College of Cardiology · 2010 · https://doi.org/10.1016/j.jacc.2010.01.027
Diagnosis and Assessment of Pulmonary Arterial Hypertension
Journal of the American College of Cardiology · 2009 · https://doi.org/10.1016/j.jacc.2009.04.011
Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review
European Respiratory Journal · 2009 · https://doi.org/10.1183/09031936.00145608
Borderline Pulmonary Arterial Pressure Is Associated with Decreased Exercise Capacity in Scleroderma
American Journal of Respiratory and Critical Care Medicine · 2009 · https://doi.org/10.1164/rccm.200904-0563oc
Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension
Journal of the American College of Cardiology · 2009 · https://doi.org/10.1016/j.jacc.2009.04.008
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
Circulation · 2008 · https://doi.org/10.1161/circulationaha.107.742510
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
Human Mutation · 2006 · https://doi.org/10.1002/humu.20285
Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension
Circulation · 2006 · https://doi.org/10.1161/circulationaha.106.618397
Ambrisentan Therapy for Pulmonary Arterial Hypertension
Journal of the American College of Cardiology · 2005 · https://doi.org/10.1016/j.jacc.2005.04.050
Diagnosis and differential assessment of pulmonary arterial hypertension
Journal of the American College of Cardiology · 2004 · https://doi.org/10.1016/j.jacc.2004.02.032
Inhaled Iloprost for Severe Pulmonary Hypertension
New England Journal of Medicine · 2002 · https://doi.org/10.1056/nejmoa020204
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
The Lancet · 2002 · https://doi.org/10.1016/s0140-6736(02)11024-5
Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension
Annals of Internal Medicine · 2002 · https://doi.org/10.7326/0003-4819-136-7-200204020-00008
Enhanced Release of Superoxide from Polymorphonuclear Neutrophils in Obstructive Sleep Apnea
American Journal of Respiratory and Critical Care Medicine · 2000 · https://doi.org/10.1164/ajrccm.162.2.9908091
Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis
American Journal of Respiratory and Critical Care Medicine · 1999 · https://doi.org/10.1164/ajrccm.160.2.9810008
Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension
Annals of Internal Medicine · 1996 · https://doi.org/10.7326/0003-4819-124-9-199605010-00006
Current projects
No projects listed.